CGON
CGON
NASDAQ · Biotechnology

Cg Oncology Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$77.74
-0.51 (-0.65%)
As of Sep 22, 9:56 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 19 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target -53.8% upside
Low Target $23.54
Average Target $35.94
High Target $41.91
Current Price $77.74
Current
$77.74
Target
$35.94
$23.54 $35.94 avg $41.91
Scenario Analysis
Bear Case
$23.54
-69.7%
Low target
Base Case
$35.94
-53.8%
Avg target
Bull Case
$41.91
+-46.1%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$80.97
-4.0% from high
52-Week Low
$35.64
+118.1% from low
50-Day SMA
$47.74
+62.8% vs SMA
200-Day SMA
$36.07
+115.5% vs SMA
RSI (14)
57.5
Neutral
Target vs 52W High
$35.94
-55.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%